Skip to main content
. 2022 May 11;6(6):e718. doi: 10.1097/HS9.0000000000000718

Figure 3.

Figure 3.

Pathophysiology of reduced VWF levels are associated with VWF and FVIII levels and BS in type 1 VWD patients with a variant. (A, B) Patients with reduced synthesis/secretion or increased clearance have lower VWF:Ag and VWF:Ab than patients with undetermined pathophysiological defects of VWF. (C) Patients with increased clearance and both reduced synthesis/secretion and increased clearance of VWF also have lower FVIII:C compared to patients with undetermined pathophysiology. (D) BS is higher in patients with increased clearance of VWF compared with those with undetermined pathophysiological defects of VWF. Data are presented as mean and 95% CI and 1reduced secretion of VWF. *P < 0.05, **P < 0.001. ns compared with patient with undetermined pathophysiological defects of VWF. Linear regression is used to compare each group with patients with undetermined pathophysiological defects of VWF. Regression analysis are adjusted for age, sex and blood group. Analysis with BS as outcome are not adjusted for blood group. BS = bleeding score; CI = confidence intervals; ns = not significant; Ref = reference; VWD = von Willebrand disease.